LTR Pharma (ASX:LTP) said its joint venture partner, Restorative Sexual Health Clinic, launched an online healthcare platform ahead of schedule for Australian men, according to a Thursday filing with the Australian bourse.
The platform will provide evidence-based care for erectile dysfunction through telehealth consultations, the filing said.
The clinical-stage pharmaceutical company also noted that the platform provides an additional channel for delivering Spontan, its intranasal spray treatment for erectile dysfunction.